Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Trial ID or NCT#
NCT00437060
Status
NOT RECRUITING
Purpose
This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.
Official Title
A Study of Neurocognitive Function in Children Treated for ALL
Eligibility Criteria
Ages Eligible for Study: 1 Year to 17 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Exclusion Criteria:
Investigator(s)
Neyssa Marina
Paul Graham Fisher, MD
Neuro-oncologist,
Pediatric neurologist
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Contact us to find out if this trial is right for you.
Contact
Pediatric Hematology/Oncology
650-723-5535
View on